Literature DB >> 23847305

Quantitative measurement of hard exudates in patients with diabetes and their associations with serum lipid levels.

Mariko Sasaki1, Ryo Kawasaki, Jonathan E Noonan, Tien Yin Wong, Ecosse Lamoureux, Jie Jin Wang.   

Abstract

PURPOSE: To describe a reproducible method of quantifying macular hard exudates (HEs) in diabetic maculopathy and determine the associations of HEs with systemic risk factors.
METHODS: Patients with diabetes were recruited from a tertiary eye hospital in Melbourne, Australia. Total macular area covered by HEs (total HE area) and the distance from the foveal center to the nearest HE were measured in a semi-automated manner. Associations between HE parameters and diabetic complication risk factors were examined using multiple linear regression models.
RESULTS: Of 593 participants (mean age 60.5-years old), 97 (16.4%) had HEs in at least one eye, due to diabetic maculopathy. The intraclass correlation coefficients (ICC) for inter- and intra-observer agreements were 0.982 and 0.999, respectively. Total HE area was positively associated with qualitative HE severity scale determined by photographic graders. The median of total HE area was 0.089 mm(2) (interquartile range, 0.027-0.246). The median distance between foveal center and the nearest HE was 791.1 μm (431.9-1385.4). After adjusting for age, sex, duration of diabetes, glycated hemoglobin, mean arterial pressure, diabetic retinopathy level, and use of lipid-lowering medication, low density lipoprotein (LDL) cholesterol (P = 0.009), and triglyceride levels (P = 0.036) were positively associated with total HE area. Higher triglyceride levels were associated with central involvement (P = 0.023).
CONCLUSIONS: Quantitative measurement of HEs in patients with diabetes is associated with lipid levels, and higher triglyceride levels are associated with a higher risk of central involvement. Quantitative information may be useful to monitor HE progression or treatment response in persons with diabetic maculopathy.

Entities:  

Keywords:  diabetes; diabetic macular edema; hard exudate; quantitative measurement; serum lipid

Mesh:

Substances:

Year:  2013        PMID: 23847305     DOI: 10.1167/iovs.13-11849

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  18 in total

1.  Association of serum lipid levels with retinal hard exudate area in African Americans with type 2 diabetes.

Authors:  Evangelia Papavasileiou; Samaneh Davoudi; Ramak Roohipoor; Heeyoon Cho; Shreyas Kudrimoti; Heather Hancock; James G Wilson; Christopher Andreoli; Deeba Husain; Maurice James; Alan Penman; Ching J Chen; Lucia Sobrin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-09-15       Impact factor: 3.117

2.  Effect of focal laser photocoagulation in eyes with mild to moderate non-proliferative diabetic retinopathy.

Authors:  Seong Hun Jeong; Jung Il Han; Sung Won Cho; Dong Won Lee; Chul Gu Kim; Tae Gon Lee; Jong Woo Kim
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

3.  Characteristics of retinal vein occlusion with final vision better than 78 letters after sequential therapy with ranibizumab and triamcinolone acetate.

Authors:  Yao-Wu Qin; Jia Yu; Quan Zhang
Journal:  Int J Ophthalmol       Date:  2017-02-18       Impact factor: 1.779

4.  Quantitative evaluation of hard exudates in diabetic macular edema by multicolor imaging and their associations with serum lipid levels.

Authors:  Ruowen Gong; Ruyi Han; Jingli Guo; Wei Liu; Gezhi Xu
Journal:  Acta Diabetol       Date:  2021-04-02       Impact factor: 4.280

5.  OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS OF MACULAR EDEMA AND HARD EXUDATES AND THEIR ASSOCIATION WITH LIPID SERUM LEVELS IN TYPE 2 DIABETES.

Authors:  Samaneh Davoudi; Evangelia Papavasileiou; Ramak Roohipoor; Heeyoon Cho; Shreyas Kudrimoti; Heather Hancock; Suzanne Hoadley; Christopher Andreoli; Deeba Husain; Maurice James; Alan Penman; Ching J Chen; Lucia Sobrin
Journal:  Retina       Date:  2016-09       Impact factor: 4.256

6.  Effects of intravitreal conbercept before panretinal photocoagulation on lipid exudates in diabetic macular documented by optical coherence tomography.

Authors:  Jing-Rong Shi; Quan Zhang; Ting Zhang; Hong Zhuang; Zhong-Cui Sun; Yao-Wu Qin
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

7.  Predictors of Development and Progression of Retinopathy in Patients with Type 2 Diabetes: Importance of Blood Pressure Parameters.

Authors:  Claudia R L Cardoso; Nathalie C Leite; Eduardo Dib; Gil F Salles
Journal:  Sci Rep       Date:  2017-07-07       Impact factor: 4.379

8.  Semi-automated quantification of hard exudates in colour fundus photographs diagnosed with diabetic retinopathy.

Authors:  Abhilash Goud Marupally; Kiran Kumar Vupparaboina; Hari Kumar Peguda; Ashutosh Richhariya; Soumya Jana; Jay Chhablani
Journal:  BMC Ophthalmol       Date:  2017-09-20       Impact factor: 2.209

9.  Factors associated with non-proliferative diabetic retinopathy in patients with type 1 and type 2 diabetes: the Japan Diabetes Complication and its Prevention prospective study (JDCP study 4).

Authors:  Ryo Kawasaki; Shigehiko Kitano; Yukihiro Sato; Hidetoshi Yamashita; Rimei Nishimura; Naoko Tajima
Journal:  Diabetol Int       Date:  2018-04-26

10.  Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections.

Authors:  Yong Un Shin; Eun Hee Hong; Han Woong Lim; Min Ho Kang; Mincheol Seong; Heeyoon Cho
Journal:  BMC Ophthalmol       Date:  2017-10-03       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.